ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

COLL Collegium Pharmaceutical Inc

33.14
0.00 (0.00%)
2024年6月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Collegium Pharmaceutical Inc COLL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 33.14 09:00:00
始値 安値 高値 終値 前日終値
33.14
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3102:11EDGAR2Form 144 - Report of proposed sale of securities
2024/5/3000:19EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
2024/5/2923:05EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2921:00GLOBECollegium to Participate in Jefferies Global Healthcare..
2024/5/2905:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2901:12EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2823:05EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2505:05EDGAR2Form 8-K - Current report
2024/5/2502:01EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2405:22EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2105:05EDGAR2Form 8-K - Current report
2024/5/1708:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1708:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1708:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1708:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1708:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1708:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1708:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1321:05EDGAR2Form 8-K - Current report
2024/5/1321:00GLOBECollegium Announces $35 Million Accelerated Share Repurchase..
2024/5/1021:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/5/1021:02EDGAR2Form 8-K - Current report
2024/5/1005:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:02GLOBECollegium Reports First Quarter 2024 Financial Results
2024/5/1005:01GLOBECollegium Announces CEO Transition
2024/4/2921:00GLOBECollegium Announces Authorized Generic Agreement with Hikma..
2024/4/2521:00GLOBECollegium to Report First Quarter 2024 Financial Results on..
2024/4/1121:00GLOBECollegium Pharmaceutical, Inc. Announces Redemption of..
2024/4/0321:00GLOBECollegium to Participate in 23rd Annual Needham Virtual..
2024/3/0506:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:24EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2706:39EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2306:09GLOBECollegium Reports Record Fourth Quarter and Full-Year 2023..
2024/2/2306:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2306:01EDGAR2Form 8-K - Current report
2024/2/1506:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1502:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0822:00GLOBECollegium to Report Fourth Quarter and Full-Year 2023..
2024/1/1906:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1706:20EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0322:03EDGAR2Form 8-K - Current report
2024/1/0322:00GLOBECollegium Provides 2024 Financial Guidance
2023/12/2306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2206:15EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2107:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:28EDGAR2Form 144 - Report of proposed sale of securities